CRISPR patent results – Nature.com


Wall Street Journal (subscription)

CRISPR patent results
Nature.com
The CRISPR–Cas9 gene-editing technology was developed from prokaryotic defence systems and has been widely adopted for genome editing in eukaryotes. A controversial battle has been waging in the United States between the Broad Institute in …
DIY Gene Editing: Fast, Cheap—and WorrisomeWall Street Journal (subscription)



all 2 news articles »

2017-02-27 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.